Thiomers exhibit properties potentially useful for non-invasive drug delivery via oral, ocular, nasal, vesical, buccal and vaginal routes. Thiomers show also potential in the field of tissue engineering and regenerative medicine. Various thiomers such as thiolated chitosan[16] and thiolated hyaluronic acid[17] are commercialy available as scaffold materials. Thiomers can be directly compressed to tablets or given as solutions.[18][19] In 2012, a second generation of thiomers – called "preactivated" or "S-protected" thiomers – were introduced.[20]
In contrast to thiomers of the first generation, preactivated thiomers are stable towards oxidation and display comparatively higher mucoadhesive and permeation enhancing properties.[21] Approved thiomer products for human use are for example eyedrops for treatment of dry eye syndrome or adhesive gels for treatment of nickel allergy.[22]
^Bernkop-Schnürch, A; Scholler, S; Biebel, RG (2000). "Development of controlled drug release systems based on polymer-cysteine conjugates". J. Control. Release. 66 (1): 39–47. doi:10.1016/S0168-3659(99)00256-4. PMID10708877.
^Bernkop-Schnürch, Andreas; Schwarz, Veronika; Steininger, Sonja (1999). "Polymers with Thiol Groups: A New Generation of Mucoadhesive Polymers". Pharm. Res. 16 (11): 876–881. doi:10.1016/j.addr.2005.07.002. PMID16176846.
^Bernkop-Schnürch, Andreas; Steininger, Sonja (2000). "Synthesis and characterisation of mucoadhesive thiolated polymers". Int. J. Pharm. 194 (2): 239–247. doi:10.1016/S0378-5173(99)00387-7. PMID10692648.
^Laffleur, F; Bacher, L; Vanicek, S; Menzel, C; Muhammad, I (2016). "Next generation of buccadhesive excipient: Preactivated carboxymethyl cellulose". Int J Pharm. 500 (1–2): 120–127. doi:10.1016/j.ijpharm.2016.01.012. PMID26773600.
^Leonaviciute, G; Suchaoin, W; Matuszczak, B; Lam, HT; Mahmood, A; Bernkop-Schnürch, A (2016). "Preactivated thiolated pullulan as a versatile excipient for mucosal drug targeting". Carbohydr Polym. 151: 743–751. doi:10.1016/j.carbpol.2016.06.005. PMID27474621.
^Priya, SS; Rekha, MR (2016). "Disulphide cross linked pullulan based cationic polymer for improved gene delivery and efflux pump inhibition". Colloids Surf B. 146: 879–887. doi:10.1016/j.colsurfb.2016.07.013. PMID27459414.
^Jelkmann, M; Bonengel, S; Menzel, C; Markovic, S; Bernkop-Schnürch, A (2018). "New perspectives of starch: Synthesis and in vitro assessment of novel thiolated mucoadhesive derivatives". Int J Pharm. 546 (1–2): 70–77. doi:10.1016/j.ijpharm.2018.05.028. PMID29758345. S2CID44071363.
^Duggan, S; O'Donovan, O; Owens, E; Cummins, W; Hughes, H (2015). "Synthesis of mucoadhesive thiolated gelatin using a two-step reaction process". Eur. J. Pharm. Biopharm. 91: 75–81. doi:10.1016/j.ejpb.2015.01.027. PMID25661588.
^Hornof, M; Weyenberg, W; Ludwig, A; Bernkop-Schnürch, A (2003). "Mucoadhesive ocular insert based on thiolated poly(acrylic acid): development and in vivo evaluation in humans". J. Control. Release. 89 (3): 419–428. doi:10.1016/S0168-3659(03)00135-4. PMID12737844.
^Ijaz, M; Prantl, M; Lupo, N; Laffleur, F; Hussain Asim, M; Matuszczak, B; Bernkop-Schnürch, A (2017). "Development of pre-activated α-cyclodextrin as a mucoadhesive excipient for intra-vesical drug delivery". Int. J. Pharm. 534 (1–2): 339–347. doi:10.1016/j.ijpharm.2017.10.054. PMID29111098.